329 related articles for article (PubMed ID: 23686938)
21. Topical hemostasis: a valuable adjunct to control bleeding in the operating room, with a special focus on thrombin and fibrin sealants.
Doria C; Vaccino S
Expert Opin Biol Ther; 2009 Feb; 9(2):243-7. PubMed ID: 19236254
[TBL] [Abstract][Full Text] [Related]
22. Combination of a liquid fibrin sealant with sheet-type hemostatic agents: experimental evaluation in partial nephrectomy animal model.
Ishii K; Kawashima H; Hayama T; Asai T; Kamikawa S; Sakamoto W; Miyabashira S; Oka S; Sugimoto T
Int J Urol; 2011 Jun; 18(6):478-82. PubMed ID: 21488977
[TBL] [Abstract][Full Text] [Related]
23. Hemostats, sealants, and adhesives III: a new update as well as cost and regulatory considerations for components of the surgical toolbox.
Spotnitz WD; Burks S
Transfusion; 2012 Oct; 52(10):2243-55. PubMed ID: 22612730
[TBL] [Abstract][Full Text] [Related]
24. Topical recombinant human thrombin in surgical hemostasis.
Bowman LJ; Anderson CD; Chapman WC
Semin Thromb Hemost; 2010 Jul; 36(5):477-84. PubMed ID: 20632245
[TBL] [Abstract][Full Text] [Related]
25. Topical hemostatic agents in surgery: a surgeon's perspective.
Samudrala S
AORN J; 2008 Sep; 88(3):S2-11. PubMed ID: 18790097
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the hemostatic potential of modern topical sealants on arterial and venous anastomoses: an experimental porcine study.
Fonouni H; Kashfi A; Majlesara A; Stahlheber O; Konstantinidis L; Kraus TW; Mehrabi A; Oweira H
J Mater Sci Mater Med; 2017 Sep; 28(9):134. PubMed ID: 28755096
[TBL] [Abstract][Full Text] [Related]
27. Topical thrombins: benefits and risks.
Lomax C; Traub O
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):8S-12S. PubMed ID: 19558279
[TBL] [Abstract][Full Text] [Related]
28. Patient blood management: use of topical hemostatic and sealant agents.
Ozawa S
AORN J; 2013 Nov; 98(5):461-78. PubMed ID: 24209796
[TBL] [Abstract][Full Text] [Related]
29. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery.
Saha SP; Muluk S; Schenk W; Burks SG; Grigorian A; Ploder B; Presch I; Pavlova BG; Hantak E
Ann Vasc Surg; 2011 Aug; 25(6):813-22. PubMed ID: 21514114
[TBL] [Abstract][Full Text] [Related]
30. Assessment of topical hemostats in a renal hemorrhage model in heparinized rats.
Tuthill DD; Bayer V; Gallagher AM; Drohan WN; MacPhee MJ
J Surg Res; 2001 Feb; 95(2):126-32. PubMed ID: 11162035
[TBL] [Abstract][Full Text] [Related]
31. Silk Fibroin-Based Biomaterials for Hemostatic Applications.
Sultan MT; Hong H; Lee OJ; Ajiteru O; Lee YJ; Lee JS; Lee H; Kim SH; Park CH
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625588
[TBL] [Abstract][Full Text] [Related]
32. Obtaining rapid and effective hemostasis: Part I. Update and review of topical hemostatic agents.
Howe N; Cherpelis B
J Am Acad Dermatol; 2013 Nov; 69(5):659.e1-659.e17. PubMed ID: 24124834
[TBL] [Abstract][Full Text] [Related]
33. The effects of sheet-type absorbable topical collagen hemostat used to prevent pulmonary fistula after lung surgery.
Miyamoto H; Sakao Y; Sakuraba M; Oh S; Takahashi N; Miyasaka Y; Akaboshi T; Inagaki T
Ann Thorac Cardiovasc Surg; 2010 Aug; 16(1):16-20. PubMed ID: 20190704
[TBL] [Abstract][Full Text] [Related]
34. Fibrin sealants: surgical hemostat, sealant and adhesive.
Mandell SP; Gibran NS
Expert Opin Biol Ther; 2014 Jun; 14(6):821-30. PubMed ID: 24625330
[TBL] [Abstract][Full Text] [Related]
35. Optimizing hemostatic practices: matching the appropriate hemostat to the clinical situation.
Neveleff DJ
AORN J; 2012 Nov; 96(5):S1-S17. PubMed ID: 23107037
[TBL] [Abstract][Full Text] [Related]
36. Evolution of hemostatic agents in surgical practice.
Sundaram CP; Keenan AC
Indian J Urol; 2010 Jul; 26(3):374-8. PubMed ID: 21116358
[TBL] [Abstract][Full Text] [Related]
37. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.
Rodgers GM
J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719
[TBL] [Abstract][Full Text] [Related]
38. Safety and hemostatic efficacy of fibrin pad in partial nephrectomy: results of an open-label phase I and a randomized, standard-of-care-controlled phase I/II study.
Nativ O; Patel B; Shen J; Batiller J; Horn S; Hart JC
BMC Nephrol; 2012 Nov; 13():147. PubMed ID: 23137020
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive review of topical hemostatic agents: The good, the bad, and the novel.
Tompeck AJ; Gajdhar AUR; Dowling M; Johnson SB; Barie PS; Winchell RJ; King D; Scalea TM; Britt LD; Narayan M
J Trauma Acute Care Surg; 2020 Jan; 88(1):e1-e21. PubMed ID: 31626024
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the thrombogenicity of internationally available fibrin sealants in an established microsurgical model.
Frost-Arner L; Spotnitz WD; Rodeheaver GT; Drake DB
Plast Reconstr Surg; 2001 Nov; 108(6):1655-60. PubMed ID: 11711942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
